Results 261 to 270 of about 9,630,957 (406)

Incidence and Management of Splanchnic Vein Thrombosis in Pancreatic Diseases. [PDF]

United European Gastroenterol J
Borbély RZ, Teutsch B, Hegyi P.
europepmc   +1 more source

Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases: Workshop Proceedings. [PDF]

Pancreas, 2022
Mastracci TL, Apte M, Amundadottir LT, Alvarsson A, Artandi S, Bellin MD, Bernal-Mizrachi E, Caicedo A, Campbell-Thompson M, Cruz-Monserrate Z, El Ouaamari A, Gaulton KJ, Geisz A, Goodarzi MO, Hara M, Hull-Meichle RL, Kleger A, Klein AP, Kopp JL, Kulkarni RN, Muzumdar MD, Naren AP, Oakes SA, Olesen SS, Phelps EA, Powers AC, Stabler CL, Tirkes T, Whitcomb DC, Yadav D, Yong J, Zaghloul NA, Sander M, Pandol SJ.   +33 more
europepmc   +1 more source

Diagnosis of Pancreatic Diseases by Scintigraphy

, 1974
Masatada TANABE, Toyosato TAMAI, Yoshio Hiraki, Kazuhiko Ehara, Hisao Takagi, Yoshio Haisa, Yasumasa KUMADA, Hiroshi Wakabayashi, Gonosuke Hashimoto   +8 more
openalex   +2 more sources

Pancreatic duct abnormalities in gall stone disease: an endoscopic retrograde cholangiopancreatographic study. [PDF]

, 1990
S P Misra, Parul Gulati, Vijayanand Choudhary, B S Anand   +3 more
openalex   +1 more source

CircRNA‐mTOR Promotes Hepatocellular Carcinoma Progression and Lenvatinib Resistance Through the PSIP1/c‐Myc Axis

Advanced Science, EarlyView.
This study verifies that circRNA‐mTOR exhibits high expression levels in HCC and has a strong correlation with patient prognosis. Mechanistically, circRNA‐mTOR achieves this effect by facilitating the nuclear translocation of RNA‐binding protein (RBP) PSIP1 through specific binding.
Yongchang Tang, Feng Yuan, Mingbo Cao, Yupeng Ren, Yuxuan Li, Gaoyuan Yang, Zhaozhong Zhong, Hao Liang, Zhiyong Xiong, Zhiwei He, Nan Lin, Meihai Deng, Zhicheng Yao   +12 more
wiley   +1 more source

Correlation Between Fatty Pancreas Disease and Pancreatic Diseases, Perioperative Complications of Pancreatic Surgery. [PDF]

Cancer Manag Res
Wu Z, Li J.
europepmc   +1 more source

SURGICAL SIGNIFICANCE OF THE SPHINCTER OF ODDI IN BILIARY AND PANCREATIC DISEASES

, 1978
Keiichi Ono, M. Shimano, Yuzuru SUGIYAMA, Akio IWAYA, Masanori OZAWA, Yoshihiro Yokoyama, Hidetoshi Suzuki, Norio KUMAKURA, Ryukichi Hada, Masao Harada, Shinobu Karouji, Kiyota Oh-Uti   +11 more
openalex   +2 more sources

Antigen‐Targeting Inserted Nanomicelles Guide Pre‐Existing Immunity to Kill Head and Neck Cancer

Advanced Science, EarlyView.
This study introduces a tumor‐targeted nanomicelle platform (preS1‐pHLIP) that exploits pre‐existing antiviral immunity to combat heterogeneous cancers. By delivering viral antigens to label tumors as virus‐like targets, the nanomicelles activate antiviral B and T cells, triggering in situ tumor lysis.
Lizhuo Zhang, Qingqing Feng, Chuanming Zheng, Yuanqiang Li, Xinyang Ge, Tiefeng Jin, Gaofeng Hu, Zhuo Tan, Jiafeng Wang, Jiajie Xu, Liehao Jiang, Dan Wang, Zhangguo Ying, Xiao Zhao, Keman Cheng, Qinglin Li, Minghua Ge   +16 more
wiley   +1 more source

Role of Sphingosine-1-Phosphate Signaling Pathway in Pancreatic Diseases. [PDF]

Int J Mol Sci
Fu F, Li W, Zheng X, Wu Y, Du D, Han C.
europepmc   +1 more source

HNF3α Targets Nckap1l and Promotes Renal Fibrosis Following Ischemia‐Reperfusion Injury

Advanced Science, EarlyView.
Hepatocyte Nuclear Factor 3 alpha (HNF3α) is significantly upregulated in renal tubular epithelial cells of CKD patients and fibrotic mice. Deletion of HNF3α mitigates IRI‐induced renal fibrosis, while overexpression worsens it. HNF3α directly regulates NCK‐associated protein 1‐like (Nckap1l), whose overexpression exacerbates fibrosis.
Ling Hou, Yan Guo, Shuang Xu, Mi Bai, Weidong Cao, Yue Zhang, Zhanjun Jia, Aihua Zhang   +7 more
wiley   +1 more source